Загрузка...
Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy
BACKGROUND: Trastuzumab (T) and anthracycline (A)-based chemotherapy is considered the standard of care in human epidermal growth factor receptor-2+ overexpressing breast cancer, but requires monitoring for known cardiotoxicity using left ventricular (LV) ejection fraction (EF) every 3–4 months duri...
Сохранить в:
| Опубликовано в: : | Nucl Med Commun |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282666/ https://ncbi.nlm.nih.gov/pubmed/30418380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNM.0000000000000941 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|